← Back to Clinical Trials
Recruiting NCT06566521

NCT06566521 Thoracic Paravertebral Block in Daytime Laparoscopic Partial Adrenalectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06566521
Status Recruiting
Phase
Sponsor Shanxi Bethune Hospital
Condition Laparoscopic Adrenalectomy
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-08-23
Primary Completion 2024-10-31

Trial Parameters

Condition Laparoscopic Adrenalectomy
Sponsor Shanxi Bethune Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2024-08-23
Completion 2024-10-31
Interventions
thoracic paravertebral block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Day surgery refers to the entire diagnostic and therapeutic process completed within 24-48 h, including patient admission, surgery, and discharge. Research by Shariq et al suggested that daytime laparoscopic adrenalectomy was a safe and effective alternative to traditional inpatient treatment. Li et al demonstrated that daytime surgery for laparoscopic partial adrenalectomy could reduce hospital stays, lower medical costs, and optimize healthcare resource utilization. The day surgery has put forward higher requirements for the management of perioperative anesthesia, in which the postoperative multimodal analgesia is particularly important.Thoracic paravertebral block (TPVB) is a regional block technique in which local anaesthetics can be injected into paravertebral space to block the ipsilateral sympathetic and somatosensory nerves. TPVB single point injection can achieve sensory block of 3-6 spinal ganglia on one side, with minimal impact on respiratory, gastrointestinal and bladder function. Especially, TPVB does not affect motor nerve, which enable patients to perform painless functional exercise shortly after surgery, promote rapid recovery, and enhance satisfaction and comfort. A large number of previous studies have shown that TPVB had become increasingly popular for postoperative analgesia after thoracic or breast surgery. However, to our knowledge, few studies to date have investigated the application of TPVB in daytime adrenal surgery. Therefore, we conducted this randomized clinical trial to examine the effect of TPVB on postoperative analgesia and the quality of recovery in patients following daytime laparoscopic partial adrenalectomy.

Eligibility Criteria

Inclusion Criteria: * Aged 18 to70 years * Body Mass Index (BMI) 18.5 to 30 kg/m² * American Society of Anesthesiologists (ASA) grade I to II classification * unilateral non-functional adrenal adenoma with a tumor diameter greater than 20mm Exclusion Criteria: * Patients with peripheral nervous system disease * Patients with spinal deformity or surgery * Patients with puncture site infection or coagulation abnormalities * Patients with history of postoperative nausea and vomiting or allergy to local anesthetics * Patients with unstable mental illness or refusal to participate

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology